Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition ...

Precision medicine and phenotyping help tailor treatments to individual patient profiles.

CPAP was more preferred by providers as treatment for obstructive sleep apnea, while patients preferred tirzepatide.

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Mosanna Therapeutics secured $80 million in a series A round to develop MOS-118 as a treatment for the nearly 1 billion ...

Mosanna Therapeutics announced today that it closed an $80 million Series A funding to support its sleep apnea therapy.

A popular weight-loss jab has been approved to treat a common sleep disorder in Australia, after a new ruling by the medicine ...

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.